SG10201503736XA - Methods for identifying and isolating cells expressing a polypeptide - Google Patents
Methods for identifying and isolating cells expressing a polypeptideInfo
- Publication number
- SG10201503736XA SG10201503736XA SG10201503736XA SG10201503736XA SG10201503736XA SG 10201503736X A SG10201503736X A SG 10201503736XA SG 10201503736X A SG10201503736X A SG 10201503736XA SG 10201503736X A SG10201503736X A SG 10201503736XA SG 10201503736X A SG10201503736X A SG 10201503736XA
- Authority
- SG
- Singapore
- Prior art keywords
- polypeptide
- identifying
- methods
- cells expressing
- isolating cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30425110P | 2010-02-12 | 2010-02-12 | |
US201161437889P | 2011-01-31 | 2011-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201503736XA true SG10201503736XA (en) | 2015-06-29 |
Family
ID=44368462
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201503736XA SG10201503736XA (en) | 2010-02-12 | 2011-02-11 | Methods for identifying and isolating cells expressing a polypeptide |
SG2012058194A SG183196A1 (en) | 2010-02-12 | 2011-02-11 | Methods for identifying and isolating cells expressing a polypeptide |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012058194A SG183196A1 (en) | 2010-02-12 | 2011-02-11 | Methods for identifying and isolating cells expressing a polypeptide |
Country Status (12)
Country | Link |
---|---|
US (5) | US8551715B2 (en) |
EP (1) | EP2534257B1 (en) |
JP (2) | JP6034696B2 (en) |
KR (1) | KR20120117931A (en) |
CN (1) | CN102844442B (en) |
AU (1) | AU2011215685B2 (en) |
CA (1) | CA2789446A1 (en) |
IL (1) | IL221349A0 (en) |
MX (1) | MX2012009175A (en) |
NZ (1) | NZ601743A (en) |
SG (2) | SG10201503736XA (en) |
WO (1) | WO2011100566A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2655362A1 (en) | 2006-06-13 | 2007-12-21 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
EP2562188A3 (en) | 2006-09-29 | 2013-03-06 | OncoMed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
JP5618544B2 (en) | 2007-01-24 | 2014-11-05 | オンコメッドファーマシューティカルズ インコーポレイテッド | Compositions and methods for diagnosis and treatment of cancer |
US8859229B2 (en) * | 2007-02-02 | 2014-10-14 | Yale University | Transient transfection with RNA |
US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
US10155038B2 (en) | 2007-02-02 | 2018-12-18 | Yale University | Cells prepared by transient transfection and methods of use thereof |
NZ590131A (en) | 2008-07-08 | 2012-10-26 | Oncomed Pharm Inc | Notch-binding agents and antagonists and methods of use thereof |
US9132189B2 (en) | 2008-07-08 | 2015-09-15 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
ES2575152T3 (en) | 2009-10-16 | 2016-06-24 | Oncomed Pharmaceuticals, Inc. | Therapeutic combination and use of DLL4 antagonist antibodies and antihypertensive agents |
KR20120117931A (en) | 2010-02-12 | 2012-10-24 | 온코메드 파마슈티칼스, 인크. | Methods for identifying and isolating cells expressing a polypeptide |
US8551479B2 (en) | 2010-09-10 | 2013-10-08 | Oncomed Pharmaceuticals, Inc. | Methods for treating melanoma |
CN110042066A (en) * | 2010-12-01 | 2019-07-23 | 默沙东公司 | The FC- bait antibody display system of surface anchoring |
US10106598B2 (en) | 2010-12-01 | 2018-10-23 | Merck Sharp & Dohme Corp. | Surface, anchored Fc-bait antibody display system |
CN104023746B (en) | 2011-07-15 | 2016-08-17 | 昂考梅德药品有限公司 | RSPO bonding agent and its application |
HUE042192T2 (en) | 2011-09-23 | 2019-06-28 | Oncomed Pharm Inc | Vegf/dll4 binding agents and uses thereof |
EP2858673A4 (en) | 2012-06-06 | 2016-06-22 | Oncomed Pharm Inc | Binding agents that modulate the hippo pathway and uses thereof |
EA032038B1 (en) | 2012-07-13 | 2019-03-29 | Онкомед Фармасьютикалс, Инк. | Rspo3-binding agents and uses thereof |
MX362456B (en) | 2012-08-24 | 2019-01-18 | Univ California | Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis. |
US20150368329A1 (en) * | 2012-10-15 | 2015-12-24 | Oncomed Pharmaceuticals, Inc. | Methods of Treating Ocular Diseases |
US8921055B2 (en) * | 2012-10-30 | 2014-12-30 | Berkeley Lights, Inc. | Detecting cells secreting a protein of interest |
WO2014071018A1 (en) | 2012-10-31 | 2014-05-08 | Oncomed Pharmaceuticals, Inc. | Methods and monitoring of treatment with a dll4 antagonist |
ES2948808T3 (en) * | 2013-03-11 | 2023-09-19 | Regeneron Pharma | Transgenic mice expressing chimeric major histocompatibility complex (MHC) class II molecules |
GB201405845D0 (en) | 2014-04-01 | 2014-05-14 | Ucl Business Plc | Signalling system |
GB201407852D0 (en) | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
GB201415347D0 (en) | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Signalling system |
AU2015338974B2 (en) | 2014-10-31 | 2021-08-26 | Oncomed Pharmaceuticals, Inc. | Combination therapy for treatment of disease |
WO2016073704A1 (en) * | 2014-11-06 | 2016-05-12 | Children's Research Institute, Children's National Medical Center | Immunotherapeutics for cancer and autoimmune diseases |
IL290459B2 (en) | 2014-12-05 | 2023-11-01 | Hope City | Cs1 targeted chimeric antigen receptor-modified t cells |
TWI715587B (en) | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Tigit-binding agents and uses thereof |
US11339213B2 (en) | 2015-09-23 | 2022-05-24 | Mereo Biopharma 5, Inc. | Methods and compositions for treatment of cancer |
SG11201811559WA (en) | 2016-06-27 | 2019-01-30 | Univ California | Cancer treatment combinations |
CN110662552A (en) | 2016-11-30 | 2020-01-07 | 昂科梅德制药有限公司 | Methods of cancer treatment comprising TIGIT binding agents |
AU2018219226A1 (en) | 2017-02-07 | 2019-08-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents |
EP3589295A4 (en) | 2017-02-28 | 2020-11-04 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
SG10202110530WA (en) * | 2017-03-24 | 2021-11-29 | Lankenau Inst Medical Res | Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas |
WO2019144095A1 (en) | 2018-01-22 | 2019-07-25 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Methods of use for car t cells |
CN112996819A (en) * | 2018-08-16 | 2021-06-18 | 纪念斯隆-凯特琳癌症中心 | Cell sorting system and method of use |
CN112969476A (en) * | 2018-12-07 | 2021-06-15 | 江苏恒瑞医药股份有限公司 | Multispecific protein molecules |
CN109738506B (en) * | 2019-01-10 | 2021-02-26 | 青岛大学附属医院 | Research method for acetylation sites of autophagy-related proteins in mature adipocytes |
US20220177912A1 (en) * | 2019-04-12 | 2022-06-09 | The Methodist Hospital | Therapeutic particles that enable antigen presenting cells to attack cancer cells |
CA3229003A1 (en) | 2021-08-25 | 2023-03-02 | Kothai Nachiar Devi PARTHIBAN | Preparation of libraries of protein variants expressed in eukaryotic cells |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
KR100272077B1 (en) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | Transgenic non-human animals capable of producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
PT1696031E (en) | 1991-12-02 | 2010-06-25 | Medical Res Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
US7166423B1 (en) | 1992-10-21 | 2007-01-23 | Miltenyi Biotec Gmbh | Direct selection of cells by secretion product |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
US7264963B1 (en) | 1995-08-18 | 2007-09-04 | Morphosys Ag | Protein(poly)peptide libraries |
PT859841E (en) | 1995-08-18 | 2002-11-29 | Morphosys Ag | PROTEIN LIBRARIES / (POLY) PEPTIDES |
WO1998018809A1 (en) | 1996-10-25 | 1998-05-07 | Cell Genesys, Inc. | Targeted cytolysis of cancer cells |
AU6537798A (en) * | 1997-03-14 | 1998-10-12 | Denise Casentini-Borocz | Targeted cytolysis of cancer cells |
CN1192109C (en) * | 1997-03-26 | 2005-03-09 | 帝国学院创新有限公司 | Anticoagulant fusion protein anchored to cell membrane |
US5837994C1 (en) | 1997-04-02 | 2001-10-16 | Gentex Corp | Control system to automatically dim vehicle head lamps |
US7176179B1 (en) * | 1997-05-30 | 2007-02-13 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
JP3614866B2 (en) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ,インコーポレイティド | Artificial antibody polypeptide |
US6180343B1 (en) | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
US6197294B1 (en) * | 1998-10-26 | 2001-03-06 | Neurotech S.A. | Cell surface molecule-induced macrophage activation |
DE19900635A1 (en) * | 1999-01-11 | 2000-07-13 | Deutsches Krebsforsch | Selection of monoclonal antibodies |
CA2339889C (en) | 1999-07-02 | 2012-01-31 | Morphosys Ag | Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
US7498304B2 (en) * | 2000-06-16 | 2009-03-03 | Curis, Inc. | Angiogenesis-modulating compositions and uses |
US7094571B2 (en) | 2000-10-27 | 2006-08-22 | The Board Of Regents Of The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
CN1306272C (en) * | 2000-11-17 | 2007-03-21 | 罗切斯特大学 | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
EP1392859B1 (en) | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
EP1392818A4 (en) * | 2001-04-30 | 2005-01-05 | Hope City | Chimeric immunoreceptor useful in treating human cancers |
AU2003240005B2 (en) | 2002-06-14 | 2010-08-12 | Takeda Pharmaceutical Company Limited | Recombination of nucleic acid library members |
JP4748984B2 (en) * | 2002-06-16 | 2011-08-17 | ダイアックス、コープ | Recombination of nucleic acid library members |
DE60336023D1 (en) * | 2002-07-15 | 2011-03-24 | Univ Texas | SCREENING OF COMBINATORY PROTEIN LIBRARIES BY PERIPLASMATIC EXPRESSION |
FR2849039B1 (en) * | 2002-12-24 | 2010-10-01 | Centre Nat Rech Scient | NOVEL PROTEIN ASSOCIATED WITH CENTROSOMES AND ITS APPLICATIONS |
US20070048740A1 (en) | 2003-02-14 | 2007-03-01 | Research Association For Biotechnology | Full-length cDNA |
EP1447413A3 (en) * | 2003-02-14 | 2006-01-04 | Research Association for Biotechnology | Full-length human cDNA |
US7479538B2 (en) * | 2004-11-12 | 2009-01-20 | The Zhabilov Trust | Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV |
CA2625619A1 (en) * | 2005-10-14 | 2007-04-26 | Medimmune, Inc. | Cell display of antibody libraries |
US20110038854A1 (en) * | 2006-03-30 | 2011-02-17 | University Of Medicine And Dentistry Of New Jersey | Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |
US20110076752A1 (en) * | 2007-02-09 | 2011-03-31 | Medimmune, Llc | Antibody library display by yeast cell plasma membrane |
US8067339B2 (en) * | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
KR20120117931A (en) | 2010-02-12 | 2012-10-24 | 온코메드 파마슈티칼스, 인크. | Methods for identifying and isolating cells expressing a polypeptide |
CN110042066A (en) * | 2010-12-01 | 2019-07-23 | 默沙东公司 | The FC- bait antibody display system of surface anchoring |
-
2011
- 2011-02-11 KR KR1020127023732A patent/KR20120117931A/en not_active Application Discontinuation
- 2011-02-11 MX MX2012009175A patent/MX2012009175A/en active IP Right Grant
- 2011-02-11 SG SG10201503736XA patent/SG10201503736XA/en unknown
- 2011-02-11 NZ NZ601743A patent/NZ601743A/en not_active IP Right Cessation
- 2011-02-11 CN CN201180009377.8A patent/CN102844442B/en not_active Expired - Fee Related
- 2011-02-11 CA CA2789446A patent/CA2789446A1/en not_active Abandoned
- 2011-02-11 SG SG2012058194A patent/SG183196A1/en unknown
- 2011-02-11 JP JP2012553038A patent/JP6034696B2/en not_active Expired - Fee Related
- 2011-02-11 WO PCT/US2011/024554 patent/WO2011100566A2/en active Application Filing
- 2011-02-11 AU AU2011215685A patent/AU2011215685B2/en not_active Ceased
- 2011-02-11 US US13/025,733 patent/US8551715B2/en not_active Expired - Fee Related
- 2011-02-11 EP EP11742877.1A patent/EP2534257B1/en active Active
-
2012
- 2012-08-08 IL IL221349A patent/IL221349A0/en unknown
-
2013
- 2013-09-06 US US14/020,012 patent/US9023621B2/en active Active
- 2013-09-06 US US14/020,030 patent/US8945878B2/en not_active Expired - Fee Related
-
2015
- 2015-04-03 US US14/678,592 patent/US9422546B2/en not_active Expired - Fee Related
-
2016
- 2016-07-14 US US15/210,250 patent/US9873726B2/en not_active Expired - Fee Related
- 2016-07-14 JP JP2016139165A patent/JP2017014220A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20170002054A1 (en) | 2017-01-05 |
US8945878B2 (en) | 2015-02-03 |
AU2011215685A1 (en) | 2012-08-30 |
EP2534257B1 (en) | 2017-09-27 |
CN102844442A (en) | 2012-12-26 |
WO2011100566A3 (en) | 2011-10-06 |
JP2013519379A (en) | 2013-05-30 |
US20110287979A1 (en) | 2011-11-24 |
US9023621B2 (en) | 2015-05-05 |
SG183196A1 (en) | 2012-09-27 |
IL221349A0 (en) | 2012-10-31 |
CA2789446A1 (en) | 2011-08-18 |
MX2012009175A (en) | 2012-12-17 |
KR20120117931A (en) | 2012-10-24 |
JP2017014220A (en) | 2017-01-19 |
US8551715B2 (en) | 2013-10-08 |
AU2011215685B2 (en) | 2015-08-20 |
NZ601743A (en) | 2014-11-28 |
CN102844442B (en) | 2016-09-07 |
US9873726B2 (en) | 2018-01-23 |
EP2534257A4 (en) | 2013-11-20 |
JP6034696B2 (en) | 2016-11-30 |
US20150315565A1 (en) | 2015-11-05 |
US9422546B2 (en) | 2016-08-23 |
EP2534257A2 (en) | 2012-12-19 |
US20140005077A1 (en) | 2014-01-02 |
WO2011100566A2 (en) | 2011-08-18 |
US20140005076A1 (en) | 2014-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL221349A0 (en) | Methods for identifying and isolating cells expressing a polypeptide | |
HK1220809A1 (en) | Structure and method for extending battery life | |
EP2629350A4 (en) | Battery case lid and manufacturing method for battery case lid | |
PT2725840E (en) | Method and device for handling cell outage | |
SG10201509185UA (en) | System for identifying and sorting living cells | |
EP2659448A4 (en) | Matching techniques for cross-platform monitoring and information | |
IL226156B (en) | Electrochemical separation system and a method of assembling the same | |
EP2648261A4 (en) | Method for manufacturing battery cell and battery cell produced using same | |
GB201000375D0 (en) | T Cell clonotypes | |
EP2542888A4 (en) | Method and kit for isolating target cell | |
EP2660892A4 (en) | Film covered battery and method for screening same | |
EP2555371A4 (en) | Battery pack and battery control system | |
EP2646283A4 (en) | Loading analysis system and method | |
EP2584635A4 (en) | Fuel cell and method for manufacturing fuel cell | |
PL2548247T3 (en) | Battery recycling method | |
GB201118180D0 (en) | Method of identifying a material | |
EP2562246A4 (en) | Cell observation device and cell observation method | |
EP2533348A4 (en) | Charging system and charging method | |
EP2655220A4 (en) | Automated case order sequencing method and system | |
GB201222753D0 (en) | Fuelling arrangement and method | |
EP2597716A4 (en) | Fuel cell system and operating method thereof | |
EP2521789A4 (en) | Vectors and methods for transducing b cells | |
EP2533347A4 (en) | Charging method | |
EP2541661A4 (en) | Electrochemical device and method for manufacturing electrochemical device | |
SG10201405455UA (en) | Cells and methods for obtaining them |